Categories
Pharmaceutical

Veterinary Ophthalmic Equipment Market Booming Demand Leading To Exponential CAGR Growth By 2030 | Nanjing Redsun Optical Co., Ltd., Welch Allyn, HEINE Optotechnik GmbH & Co. KG, LKC Technologies, Inc

Demand for veterinary care has exponentially increased in recent times, due to which, demand for veterinaries and clinics has also increased. People spend more on veterinary services than on medicines. Since the advent of the Internet, knowledge sharing has helped people realize the importance of regular checkups for animals. Moreover, veterinary medical device manufacturers are emphasizing on collaborative manufacturing with regional manufacturing presence to grab a greater share in high potential untapped regions in the veterinary ophthalmic equipment market.

Moreover, growing veterinary healthcare spending and R&D investments, and increasing production of veterinary medical devices are some of the factors propelling the growth of the veterinary ophthalmic equipment market. For instance, in 2016, animal health manufacturers invested around US$ 46 Bn, whereas, non-IP-intensive industries invested around US$ 3.9 Bn in R&D. Workers in the animal health industry earned nearly 25% premium. The export per worker in the animal health industry is around two times that of the non-IP-intensive industry.

Request a report sample to gain comprehensive insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=5241

As per Fact.MR, the global veterinary ophthalmic equipment market is estimated to reach a valuation of US$ 785 Mn by the end of 2030.

Key Takeaways from Veterinary Ophthalmic Equipment Market Study
  • By product, diagnostic devices accounted for a prominent market value share in the veterinary ophthalmic equipment market, due to growing usage of these devices for various disease diagnosis applications.
  • North America and Europe collectively hold over 60% of the global veterinary ophthalmic equipment market share, owing to growing research and production activities in veterinary medical equipment manufacturing industries.
  • Based on end user, veterinary clinics accounted for more than half of the market value share in the global veterinary ophthalmic equipment market. However, the veterinary hospitals segment is expected to expand at a higher growth rate.
  • Demand for veterinary medical equipment in Europe and East Asia is also projected to surge at a significant rate during the forecast period.  Rising adoption of pets and increasing consumer spending on veterinary care are playing a crucial role in adoption of veterinary medical equipment in hospitals and clinics across the region.
  • The COVID-19 pandemic will have a short-term adverse effect on the expansion of the global veterinary ophthalmic equipment market.

veterinary ophthalmic equipment market product

“Rising adoption of pets and increasing consumer spending on veterinary care & funding are some of the factors anticipated to favor the growth of the global veterinary ophthalmic equipment market,” says a Fact.MR analyst.

Request More Information about Report Methodology
https://www.factmr.com/connectus/sample?flag=RM&rep_id=5241

Product Portfolio Expansion and Partnerships Key Strategies by Market Players

Icare Finland Oy, AMETEK, Inc. (Reichert, Inc.), HAAG-STREIT GROUP, and Nanjing Redsun Optical Co., Ltd. contributed a higher market value share in the global veterinary ophthalmic equipment market. Veterinary ophthalmic equipment manufacturers are focusing on expansion of product portfolios. For instance, in April 2019, Revenio Group acquired centerVeu to strengthen its position as a global market leader in devices for diagnostics and monitoring of eyes.

Manufacturers are also focusing on partnerships and agreements with other manufacturers to expand product sales. For instance, in April 2019, LKC Technologies announced Brazilian Health Regulatory Agency Approval for the RETeval® Device and Associated Sensor Strip Electrodes, which is another step in making functional diagnostics accessible to all clinicians, leading to faster diagnosis of complex eye diseases.

Get More Insights- https://www.prnewswire.com/news-releases/veterinary-ophthalmic-equipment-market-growth-banking-on-cataract–glaucoma-treatment-advances-for-animals-factmr-301244594.html

Looking for more information?

The research study on the veterinary ophthalmic equipment market by Fact.MR incorporates an unbiased assessment of key demand-driving factors and trends that have shaped the landscape of the veterinary ophthalmic equipment market over 2015 – 2019, and includes detailed assessment of key parameters that are anticipated to exert influence during 2020 – 2030. Market statistics have been presented on the basis of product type (diagnostic devices [tonometers, fundus cameras, portable ERG devices, ophthalmoscopes, and slit lamps] and surgical equipment [operating microscopes, phacoemulsification devices, opthalmic surgical instruments, bandage contact lenses, viscoelastics, and intraocular lenses]) and end user (veterinary medical centers and colleges, veterinary hospitals, and veterinary clinics), across seven major regions.

Explore Fact.MR’s Coverage on the Healthcare Domain

Veterinary Imaging Systems Market: A recent study by Fact.MR on the veterinary imaging systems market offers a 10-year forecast from 2017 to 2022. The study analyzes crucial trends that are currently determining market growth. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders and emerging players.

Veterinary Respiratory Ventilators Market: Fact.MR’s recent report on the veterinary respiratory ventilators market offers a forecast from 2018 to 2028, highlighting such key aspects as drivers, opportunities and trends prevailing across the aforementioned period. The report provides a detailed analysis of key segments’ growth prospects across prominent geographies, along with information on the important stakeholders and manufacturers operating in the landscape.

Veterinary Radiography Flat Panel Detectors Market: A detailed assessment of global veterinary radiography flat panel detectors value chain analysis, business execution, and supply chain analysis across the regional markets has been covered in Fact.MR’s elaborate coverage on the landscape. Statistics have been provided for key segments’ and their expansion prospects across prominent geographical locations.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Research Insight: https://www.factmr.com/report/5241/veterinary-ophthalmic-equipment-market
Press Release: https://www.factmr.com/media-release/1705/global-veterinary-ophthalmic-equipment-market
Follow Us: LinkedIn | Twitter

Categories
Pharmaceutical

Multiphoton Microscopy Market- North America followed by Europe Account for the Largest Revenue Share of the Market during Forecast Period

Growing biomedical research for drug development and diagnostics of cancer is expected to build a favorable atmosphere for the growth of the multiphoton microscopy market in the near future. Moreover, various clinical development programs in several countries are focused at increasing cancer screening programs with the help of governments. This is leading to the early screening and diagnosis of cancer patients. Multiphoton microscopy is now also being used for imaging in clinical oncology diagnostic tests. Growing prevalence of cancer across the world is expected to fuel demand for multiphoton microscopy across geographies.

Request a report sample to gain comprehensive insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=3405

Currently, players in the multiphoton microscopy space are consistently making changes in their product categories and technologies in order to enhance device capabilities. For instance, in December 2020, ZEISS introduced ZEISS Lattice lightsheet 7; this product is tailored to observe cellular processes within cells and small organisms in 3D over extended time periods, all at a subcellular resolution with minimum light dosage.

The global multiphoton microscopy market was valued at around US$ 150 Mn in 2019, and is projected to expand at a CAGR of close to 5% through 2031.

multiphoton microscopy market region

Key Takeaways from Multiphoton Microscopy Market Study
  • Two-photon microscopy accounted for 94.2% market share in 2020.
  • Deep tissue imaging is the most lucrative segment and holds nearly 18% of the market share.
  • North America and Europe collectively hold over half of the global multiphoton microscopy market share, owing to technological advancements and increasing mergers and collaborations in these regions.
  • Hospitals & clinics account for over 5% value share, since they serve as the primary centers for disease diagnosis and treatment.
  • The COVID19 pandemic has resulted in a temporary pause of all non-essential and elective procedures. Medical device manufacturers have been severely impacted, with companies reporting significant drop in revenue due to the cancellation of diagnostic procedures.

Request More Information about Report Methodology
https://www.factmr.com/connectus/sample?flag=RM&rep_id=3405

“Rising adoption of e-Commerce and increasing technological advancements are factors anticipated to aid growth of the global multiphoton microscopy market over the coming years,” says a Fact.MR analyst.

Addition of Innovative Products in Portfolio through Partnerships

To retain their positions in the market, prominent medical device manufacturers are identifying potential assets from smaller firms, which typically have limited resources to see projects through to the market. Through licensing deals and partnerships, companies are acquiring new products, while continuing to pursue their own in-house development strategies.

  • For instance, in September, 2020, Bruker Corporation announced the acquisition of Canopy Biosciences, LLC, a leader in high multiplex biomarker imaging for immunology, immuno-oncology, and cell therapy. This acquisition enhances Bruker’s offerings in targeted multi-omics and fluorescence-based imaging techniques.

Get More Insights- https://www.biospace.com/article/multiphoton-microscopy-sales-set-to-grow-at-5-percent-by-2030-end-fact-mr/

Looking for more information?

The research study on the multiphoton microscopy market by Fact.MR incorporates an unbiased assessment of key demand-driving factors and trends, which have shaped the landscape over 2015 – 2019, and includes detailed assessment of key parameters that are anticipated to exert influence during 2020 – 2030. Market statistics have been presented based on product (two-photon microscopy and three-photon microscopy), application (skin imaging, neuroscience, oncology, immunology, embryology, deep tissue imaging, functional and molecular imaging, intravital imaging, cell culture, virology, and others), and end user (hospitals & clinics, clinical & diagnostic laboratories, and academic & research institutes), across seven regions – North America, Latin America, Europe, South Asia, East Asia, Oceania, and the Middle East & Africa.

Explore Fact.MR’s Coverage on the Healthcare Domain

Microcirculation Microscope Market: A recent study by Fact.MR on the Microcirculation Microscope market offers an unbiased analysis on the opportunities and trends through 2021 and beyond. The study analyzes crucial trends that are currently determining market growth. This report explicates on vital dynamics, such as the challenges, restraints, and opportunities for key market players along with key stakeholders and emerging players.

Scanning Probe Microscopes Market: A detailed assessment of Scanning Probe Microscopes market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the market along with their product portfolios enhances the reliability of this comprehensive research study.

Microscopy Devices Market: Fact.MR delivers a detailed analysis on global Microscopy Devices market with the strategies and competitive landscape for the upcoming period. The key players’ market share data provided by the report given you a detailed insights on the shortcomings and forthcomings of the market for the forecast period.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Research Insight: https://www.factmr.com/report/3405/multiphoton-microscopy-market
Press Release: https://www.factmr.com/media-release/1804/multiphoton-microscopy-market-trend
Follow Us: LinkedIn | Twitter

Categories
Pharmaceutical

Chromatography Syringes Market is estimated to reach approximately US$ 85 Million in revenues by 2022-end

The global chromatography syringes market is projected to exhibit an impressive expansion during the forecast period 2017 to 2022, according to a new study by Fact.MR. On the back of rising consumer concerns pertaining to food safety, coupled with continuous alterations in regulatory framework, demand for chromatography syringes is expected to witness a surge. Revenues from the global market for chromatography syringes will reach roughly US$ 85 Mn by 2022-end.

Request a report sample to gain comprehensive insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=153

Increasing Requirements in Research Activities to Fuel Market Growth of Chromatography Syringes

Chromatography tests have become indispensable for approval of drugs. A number of technological advancements have been observed in chromatography syringes, which aim to cater demand from various industries such as semiconductor, chemical, food & beverage, biopharmaceutical, and biotechnology. Over the past few years, the requirements for research activities have been soaring, which include robust adoption of chromatography in proteomics, purification of monoclonal antibodies, and green chromatography. These factors are likely to fuel growth of the global chromatography syringes market.

However, difficulty in utilization of chromatography syringes in conventional methods may act as a restraining factor for growth of the market. In addition, chromatography syringes have less sample capacity, which in turn makes chromatography a very time consuming process, and careful attention is required while using these syringes. This factor is further expected to hinder the market growth in the near future.

North America – Projected to Remain the Largest Market for Chromatography Syringes

In terms of revenues, North America is projected to remain the largest market for chromatography syringes, followed by Europe. However, sales of chromatography syringes in Asia-Pacific excluding Japan will continue to register a relatively higher CAGR than other regional segments through 2022.

Although gas chromatography will continue to be the most lucrative application of chromatography syringes, sales of chromatography syringes in high pressure liquid chromatography (HPLC) application are expected to exhibit the fastest expansion through 2022. Demand for chromatography syringes for application in thin layer chromatography is anticipated to remain relatively lower than other application segments over the forecast period.

Request More Information about Report Methodology
https://www.factmr.com/connectus/sample?flag=RM&rep_id=153

Autosampler syringes for chromatography are expected to remain sought-after among products in the market, accounting for over half market revenue share during 2017 to 2022. Sales of manual chromatography syringes will continue to exhibit a lower CAGR as compared to sales of autosampler syringes through 2022.

Sales of Chromatography Syringes in Pharmaceutical Industry to Exhibit Fastest Expansion through 2022

On the basis of end-users, research institutes are expected to remain dominant in the global market for chromatography syringes, however chromatography syringes sales in pharmaceutical industry will continue to reflect the fastest expansion through 2022.

Complete loop filling will continue to be most lucrative technology adopted in the global chromatography syringes market, with sales projected to surpass US$ 30 Mn in revenues by 2022-end. Demand for partial loop filling technology for chromatography syringes are anticipated to exhibit the highest CAGR through 2022.

Get More Insights- https://www.biospace.com/article/growing-requirement-of-research-activities-to-fuel-demand-for-chromatography-syringes-market-states-fact-mr/

Key market players mentioned in Fact.MR’s report include Trajan Scientific & Medical Pty Ltd., Hamilton Company, Valiant Co., Ltd., PerkinElmer, Inc., Agilent Technologies, Shimadzu Corporation, and Thermo Fisher Scientific, Inc.

Explore Fact.MR’s lucid coverage of the Healthcare landscape

Gas Chromatography Market : The global gas chromatography market is projected to exceed US$ 3,500 Million towards the end of 2022.

Ambient Temperature Gel Permeation Chromatography Market: Need for a particular high specialized high-temperature Gel permeation chromatography system amid their molecular weight distributions analysis restrains the market growth during 2018-2026.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Research Insight: https://www.factmr.com/report/153/chromatography-syringes-market
Press Release: https://www.factmr.com/media-release/142/chromatography-syringes-market
Follow Us: LinkedIn | Twitter

Categories
Pharmaceutical

Normal Balloon Catheter Market- Europe to Account for the Largest Revenue Share of the Market during Forecast Period

Over the past few years, incidences of cardiovascular diseases have been witnessing a surge, coupled with the rising number of cardiology intervention procedures around the world. Governments are making provisions of reimbursement support for patients with vascular diseases.

Healthcare expenditure has also been experiencing a hike in the recent past. Factors such as these may impact the growth of the global normal balloon catheter market. In addition, numerous other factors including rising in the elder population, increasing investments in R&D activities associated with normal balloon catheters are further estimated to create growth opportunities for normal balloon catheter manufacturers.

Request a report sample to gain comprehensive insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=147

The global market for normal balloon catheters is set to exhibit an average CAGR throughout the forecast period (2017-2022). The global normal balloon catheter market will account for around US$ 2,000 Mn revenues by 2022-end.

However, factors such as high costs related to angioplasty procedures, along with risks concerning balloon catheterization including infection and artery collapse are anticipated to curb the growth of the global market for the normal balloon catheter.

Trends Being Observed in the Global Normal Balloon Catheter Market
  • Rise in interventional cardiology is facilitating the use of the normal balloon catheters
  • Surging prevalence of patients with end-stage renal disease have been fuelling demand for normal balloon catheters
  • The number of people undergoing renal replacement therapy is increasing, thereby fuelling the growth of the normal balloon catheter market

Normal balloon catheter sales in cardiac catheterization laboratories will register the fastest expansion over the forecast period, on the basis of end-users. In addition, hospitals are expected to retain their dominance in the global market for normal balloon catheters.

Market Taxonomy
Indication
  • Coronary Artery Disease
  • Peripheral Vascular Disease
End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Catheterization Laboratories
Raw Material
  • Polyurethane
  • Nylon
  • Others
Hospitals to Remain the Largest End-Users of Normal Balloon Catheter

Sales of normal balloon catheter in cardiac catheterization laboratories are expected to exhibit the fastest expansion through 2022, based on end-users. Hospitals will remain the largest end-users of normal balloon catheter throughout the forecast period.

Nylon will continue to be the preferred raw material for manufacturing normal balloon catheter. Nearly half the revenue share of the market will be accounted for nylon, based on raw material. However, sales of polyurethane for the production of normal balloon catheter will register a comparatively higher CAGR than sales of nylon through 2022.

Request More Information about Report Methodology
https://www.factmr.com/connectus/sample?flag=RM&rep_id=147

Nylon to be Sought-after among Manufacturers of Normal Balloon Catheters

Based on raw material, nylon will remain sought-after among manufacturers of normal balloon catheters. Approximately half market share will be held by sales of nylon in the market during the forecast period. In addition, sales of polyurethane in the global market is expected to exhibit a relatively higher CAGR than that of nylon through 2022.

Coronary artery disease will continue to be dominant in the market, based on the indication. Sales of normal balloon catheters for coronary artery disease are anticipated to exceed revenues worth US$ 1,000 Mn by 2022-end. In terms of revenue, nearly three-fourth market share is estimated to be held by normal balloon catheter sales for coronary artery disease throughout the forecast period.

Get More Insights- https://www.accesswire.com/618349/Asthma-Treatment-Market-Growth-Bolstered-by-Sales-of-Long-Term-Asthma-Control-Medications-Opines-FactMR

Europe to Account for Largest Revenue Share of the Global Normal Balloon Catheter Market

Europe is projected to be the largest market for normal balloon catheter from 2017 to 2022, in terms of revenue. Sales of a normal balloon catheter in Europe will hold the largest revenue share of the market over the forecast period. In addition, normal balloon catheter sales in Asia-Pacific excluding Japan (APEJ) are expected to exhibit the fastest expansion through 2022. In contrast, the market in North America is anticipated to register the lowest CAGR through 2022.

Key market players profiled in the report include BIOTRONIK SE & Co. KG., Cordis Corporation, Cook Medical INC, Tokai Medical Products Inc., Hexacath, Meril Life Sciences Pvt. Ltd., B. Braun Melsungen AG, MicroPort Scientific Corporation, Terumo Corporation, Medtronic plc, Boston Scientific Corporation, and Abbott Laboratories.

Explore Wide-ranging Coverage of Fact.MR’s Healthcare Landscape

Asthma Spacers Market: Find insights on the Asthma Spacers market with analysis of segments, statistics, influencers, market players, and business strategies adopted over a 10-year forecast period.

Diverticular Disease Therapeutics Market: Fact.MR’s report on the diverticular disease therapeutics market offers insights on the market during 2018-2028, including restraints, revenue sources, market leaders, and market strategies.

Tumour-Induced Osteomalacia Market: Read an analysis of the tumour-induced osteomalacia market with insights on growth factors, opportunities, restraints, regional market forecast, regulatory policies, and strengths of market leaders.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Research Insight: https://www.factmr.com/report/147/normal-balloon-catheter-market
Press Release: https://www.factmr.com/media-release/136/normal-balloon-catheter-market
Follow Us: LinkedIn | Twitter

Categories
Pharmaceutical

Asthma Treatment Market – North America is expected to have a large share, Says Fact.MR study

Retail pharmacies will drive the highest sales of asthma therapeutics with an estimated value of around US$ 17 Bn by 2027, as rapid expansion of retail pharmacies makes asthma therapeutics more accessible to patients. According to a recent Fact.MR study, hospital pharmacies with large drug inventories would also remain a crucial distribution channel in the asthma treatment market. As patients find it convenient to purchase drugs immediately after diagnosis, hospital pharmacies are likely to catalyze sales of asthma treatment during the forecast period (2020-2027). The study finds that, hospital pharmacies hold the potential to drive sales tantamount to US$ 10 Bn by 2027, in the asthma treatment market.

Request a report sample to gain comprehensive insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=4422

North America to Hold Pole Position in Asthma Treatment Market; Asia Pacific Market to Gain Pace

North America would retain its pole position in the asthma treatment market, while the market in Asia Pacific is projected to witness the fastest growth rate. During the forecast period, North America would lose its market share to Asia Pacific, as leading players are gradually scrambling towards developing countries such as China and India to cash in on relatively cost-effective production opportunities. For instance, F.Hoffmann-La Roche Ltd. announced the inauguration of a new manufacturing facility for its pharmaceutical division in Shanghai, China.

Additionally, North America accounts for a high concentration of leading players; ones that generally develop branded drugs. On the contrary, players in the Asia Pacific asthma treatment market relatively hold a low market position, and are involved in the development of generic drugs. As a result, threat of patent expiration affects the North American market more adversely than Asia Pacific. On the back of shifting market trends towards Asia Pacific, the regional asthma treatment market is projected to gain significant pace during the forecast period.

assessing lucrativeness of asthma treatment market by treatment type

Key Highlights of Asthma Treatment Market Study
  • Sales of long-term asthma control medications would remain 59% higher as compared to quick-relief medications by 2027, as rescue medications have limited application scope (only used during asthma attacks), while long-term medications possess high efficacy to control asthma attacks.
  • Loss of patent exclusivity of branded drugs could affect the position of leading players in the asthma treatment market, as generic drugs gain ground. For instance, patents of Symbicort Turbuhaler and Qvar manufactured by AstraZeneca and GlaxoSmithKline PLC respectively, are to expire in the very near future. High availability of generic drugs to treat mild to severe asthma is projected to adversely affect revenue potential of the asthma treatment market during the forecast period.
  • Sales of inhalers are projected to cross US$ 14 Bn by 2027, and oral route of administration is likely to grow as the second-most attractive section in the asthma treatment market.
  • Relaxed FDI policies in India and China are projected to shift focus of leading players towards Asia Pacific to achieve reduced overhead costs and meet growing demand for asthma therapeutics in these countries. According to the Lung India Journal, India accounts for one in every 10 asthma patients. On the back of increasing demand for asthma therapeutics and improving supply chain, the Asia Pacific asthma treatment market is projected to witness growth in the market.

Request More Information about Report Methodology
https://www.factmr.com/connectus/sample?flag=RM&rep_id=4422

A senior research analyst at Fact.MR opines, “Growing acceptance of online shopping channels offering next-day/ same-day delivery features and attractive deals would increase sales through online pharmacies. The trend of ordering medications through online pharmacies would gain more prominence by 2027.”

High Reliance of Leading Players on Organic Growth Strategy

Leading players in the consolidated asthma treatment market, accounting for 60% of the total share, rely on organic growth strategy to develop an extensive product portfolios. These players aim to develop novel therapies and drugs through high investments in R&D activities. For instance, in 2018, AstraZeneca and its partner Amgen Inc., announced that the Food and Drug Administration (FDA) had granted Breakthrough Therapy designation to Tezepelumab, which is used for the treatment of severe asthma. Continuous introduction of new therapeutics strengthens their portfolios, and well-established brand identity of leading players further increases their sales prospects.

Get More Insights- https://www.accesswire.com/618349/Asthma-Treatment-Market-Growth-Bolstered-by-Sales-of-Long-Term-Asthma-Control-Medications-Opines-FactMR

Find More Valuable Insights on Asthma Treatment Market

Fact.MR, in its new offering, brings to the fore an unbiased analysis of the global asthma treatment market, presenting historical demand data (2017-2019), and forecast statistics for the period of 2020-2027. The study divulges compelling insights on the asthma treatment market on the basis of treatment type (long-term asthma control medications and quick-relief (rescue) medications), route of administration (inhaled, oral, intravenous, and subcutaneous), and distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies), across five major regions.

Explore Wide-ranging Coverage of Fact.MR’s Healthcare Landscape

Asthma Spacers Market: Find insights on the Asthma Spacers market with analysis of segments, statistics, influencers, market players, and business strategies adopted over a 10-year forecast period.

Diverticular Disease Therapeutics Market: Fact.MR’s report on the diverticular disease therapeutics market offers insights on the market during 2018-2028, including restraints, revenue sources, market leaders, and market strategies.

Tumour-Induced Osteomalacia Market: Read an analysis of the tumour-induced osteomalacia market with insights on growth factors, opportunities, restraints, regional market forecast, regulatory policies, and strengths of market leaders.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Research Insight: https://www.factmr.com/report/4422/asthma-treatment-market
Press Release: https://www.factmr.com/media-release/1207/asthma-treatment-demand
Follow Us: LinkedIn | Twitter

Categories
Pharmaceutical

Intranasal migraine drugs Market to Witness a Tremendous Growth Due to COVID-19 Pandemic – Exclusive Report by Fact.MR

Award winning market research company Fact.MR’s ongoing research study on global intranasal migraine drugs market studies the market for the forecast period of 2021 and 2031. Rising cases of acute and chronic headache among the young-adult population is expected to increase the adoption of intranasal migraine drugs. Expansion in research and development activities for the development of novel treatments to provide quick relief for the cerebral and sinus pain will provide growth opportunities for the key players in the coming years.

According to Fact.MR, the market is expected to showcase a positive growth over the forecast period backed by the rising demand of intranasal migraine drugs from hospital & retail pharmacies. As per the analysis, around 95% of patients with migraine issues prefer the intranasal migraine drugs.

Request For A Brochure: https://www.factmr.com/connectus/sample?flag=S&rep_id=5612

There are some side-effects recorded such as quick heartbeat, muscle torment in legs/arms, and serious/moderate stomach torment that may hamper the demand. However, ongoing research & development (R&D) activities for the improvement of intranasal migraine drugs by manufacturers will overcome the constraints of the market. Hence, key players are investing heavily for the development of improved intranasal migraine drugs for the treatment of acute & chronic migraine. Thereby, bolstering the growth.

“Increasing R&D activities, new product launches by key manufacturers, and fast track drug approvals by regulatory bodies such as the U.S. Food and Drug Administration for acute and chronic migraine are expected to provide lucrative opportunities in the upcoming decade,” says the Fact.MR analyst.

Key Takeaways

  • Increasing cases of acute migraine are anticipated to spur the sales of intranasal migraine drugs
  • Hospital & retail pharmacies are anticipated to be the primary end-users for intranasal migraine drugs market
  • In terms of therapeutic class, opioids and antihistamines are expected to lead the segment throughout the forecast period
  • United States is anticipated to spearhead the Intranasal migraine drugs market growth in North America
  • UK will lead the second largest European Intranasal migraine drugs market through 2021

Prominent Drivers

  • Growing cases of chronic sinusitis are expected to accelerate the demand for Intranasal migraine drugs
  • Technological advancements in the healthcare industry for intranasal migraine drugs are expected to boost the market growth

Key Segments of Intranasal migraine drugs market Covered in the Report

Based on Intranasal migraine drugs Market, By Therapeutic class:

  • Corticosteroids
  • NSAID’S
  • Opioids
  • Antibiotics
  • Local Anaesthesia
  • Antihistamines 

Based on Intranasal migraine drugs Market, By Indication:

  • Common Migraine
  • Classic Migraine
  • Cluster Migraine
  • Others

Based on Intranasal migraine drugs Market, By Range:

  • Broad spectrum/ Chronic
  • Narrow spectrum/ Acute

Intranasal migraine drugs Market, By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Third party manufacturing companies

Share Your Requirements & Get Customized Reports : https://www.factmr.com/report/intranasal-migraine-drugs-market  

Competitive Landscape

Key players listed by Fact.MR operating in global intranasal migraine drugs market includes Aegis Therapeutics LLC, Neuro Pharma, Rd. Reddy’s Laboratories, Novartis AG, Pfizer Inc., Lockhart LTD, Roche, Sanofi, Merck, Baxter International Inc., Becton, Dickinson & Company, GlaxoSmithKline PLC and Johnson & Johnson among others. Product launches and expansion of portfolio along with strategic mergers & acquisition remains the core strategies for the aforementioned players to gain a competitive edge in the industry.

For instance, on January 20th 2021, Impel Neuro Pharma received the approval from U.S. Food and Drug Administration (FDA) for the new drug application for INP104, for the acute treatment of migraine headaches with or without aura in adults to deliver a lower dose of dihydroergotamine mesylate to the upper nasal state. 

Also, on 2nd March 2021, Cipla received U.S FDA approval for nasal spray for treating migraine attacks/

Furthermore, in June 2020, Tonix Pharmaceuticals announced the acquisition of non-addictive migraine and pain treatment programs of Trigemina Inc. and will acquire the license of TNX-1900 intranasal oxytocin has the potential to treat migraine and craniofacial pain.

More Insights on the Intranasal Migraine Drugs Market

Fact.MR sheds an in-depth analysis on global intranasal migraine drugs market over the forecast period of 2021 and 2031. In order to understand the market perspective, trends and challenges, the market is segmented on the basis of therapeutic class (corticosteroids, NSAID’s, opioids, antibiotics, local anesthesia, and antihistamines), indication (common migraine, classic migraine, cluster migraine, and others), range (chronic and acute), distribution channel (hospital pharmacies, retail pharmacies, online pharmacies, and third party manufacturing companies), and regions (North America, Latin America, Europe, CIS & Russia, Asia Pacific excluding Japan, Japan and Middle East & Africa). 

Read More Trending Reports of Fact.MR- https://www.biospace.com/article/long-term-disability-management-to-drive-bulk-of-medical-case-management-services-market-growth/

Explore Fact.MR’s Coverage on the Healthcare Domain

Bone Growth Stimulator Market: A recent study by Fact.MR on the bone growth stimulator market offers an unbiased analysis on the opportunities and trends through 2021 and beyond. The study analyzes crucial trends that are currently determining market growth.

Bone Marrow Processing System Market: Fact.MR gives a detailed assessment of bone marrow processing system market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.

Injectable Bone Graft Substitutes Market: Fact.MR delivers an in-depth analysis on global injectable bone graft substitutes market with the strategies and competitive landscape through 2021 and beyond. The key players’ market share data provided by the report given you a detailed insights on the shortcomings and forthcomings of the market for the forecast period.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-158

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com

Categories
Pharmaceutical

Non-Hormonal Steroid Modulators Market Look a Witness of Excellent Long-Term Growth – Worldwide Survey by 2031

The global non-hormonal steroid modulators market is exhibiting steady growth and the trend is expected to continue for the forecast period between 2021 and 2031.

According to World Health Organization (WHO), 1 in every 3000 individuals is affected with muscular dystrophy. Besides this, the prevalence of arthritis varies between 0.3% and 1% people. Studies have shown that women are more vulnerable compared to males. Thus, the demand for non-hormonal steroid modulators treatment to curb the incidence of arthritis creates significant opportunities for the market.

As per a study by World Health Organization (WHO), in the year 2020, around 10 million deaths were reported due to cancer. Furthermore, near about 13% of cancers diagnosed in 2018 were attributed to carcinogenic infections across the globe. As non-hormonal steroid modulators such as RU49953 play an important role in treating cancer drug resistance, the demand for non-hormonal steroid modulators is expected to soar. 

Request For A Brochure : https://www.factmr.com/connectus/sample?flag=B&rep_id=5192

Competitive Landscape 

Reveragen Biopharma inc is a leading player in the market. It has increased its focus on developing novel non-hormonal steroid modulators for expanding their portfolio and strategic collaboration with other companies. For instance,

  • In 2020, ReveraGen, Inc., introduced vamorolone (VBP15) as a safer alternative for corticosteroid treatment in Duchenne muscular dystrophy and other disorders. The company received an award of a $3.3 million from the National Institute of Neurological Disorders and Stroke (NINDS) at National Institutes of Health (NIH) for the development of novel modulators
  • ReveraGen has made collaboration with Santhera for the commercialization of novel vamorolone.

More Insights on the Non-Hormonal Steroid Modulators Market

In its latest report, Fact.MR offers an unbiased analysis of the non-hormonal steroid modulators market. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of modulator type (RU49953, and non-hormonal steroid NF-κB modulator), indication (arthritis, muscular dystrophy, and cancer drug-resistance), and across seven regions (North America, Latin America, Europe, South Asia, East Asia, Oceania and Middle East & Africa). 

Non-Hormonal Steroid Modulators Market: Segmentation

The global non-hormonal steroid modulators are segmented into by modulator type, indication and region. 

By modulator type, the global non-hormonal steroid modulators are further segmented into:

  • RU49953
  • Non-Hormonal Steroid NF-κB Modulator

By indication, the global non-hormonal steroid modulators are further segmented into:

  • Arthritis
  • Muscular Dystrophy
  • Cancer Drug-Resistance (Drug Efflux)

Share Your Requirements & Get Customized Reports : https://www.factmr.com/connectus/sample?flag=T&rep_id=5192

Non-Hormonal Steroid Modulators Market: Regional Outlook

Europe dominates the global non-hormonal steroid modulators market with its leading research studies and clinical trials, the European market is pushed by the high prevalence of arthritis in this region, and special attention of European Commission towards muscular dystrophy therapies. North America holds the second-largest non-hormonal steroid modulators market with its active R&D activities, key players and non-hormonal steroid modulators patent claimed for muscular dystrophy and arthritis.

Asia-Pacific non-hormonal steroid modulators are expected to bloom in future, with the massive burden of arthritis, escalating research and improving healthcare, along with the support of government funding. Latin America non-hormonal steroid modulator market is expected to grow moderately with improving research and healthcare. The Middle East & Africa non-hormonal steroid modulators market is expected to remain stagnant due to the under-developed medical healthcare and R&D infrastructure.

Latin America is expected to grow at a moderate rate with the gradual elevation of the research and technology. The Middle East & Africa is expected to have a stagnant growth due to the under-developed research infrastructure.

Read More Trending and Similar Reports from Fact.MR – https://www.biospace.com/article/latest-insights-on-nano-healthcare-technology-market-post-covid-fact-mr-new-report-analyzes/

Explore Fact.MR’s Coverage on the Healthcare Domain

Oral & Topical Anesthetics market: Fact.MR recently published a market study on the global oral & topical anesthetics market. The study provides detailed assessment on the key market dynamics, including drivers, trends, opportunities, and restraints, as well as detailed information about the market structure.

Alexandrite Gemstone Lasers Market: Fact. MR’s extensive coverage on alexandrite gemstone lasers market offers in-depth insights about the prominent growth dynamics that are likely to aid expansion of growth prospects in the near future.

Dermatology Devices Market: Fact.MR gives a detailed assessment of dermatology devices market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-158

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com

Categories
Pharmaceutical

Absorbent Dressing Market: Booming Demand from Emerging Economies to Market Growth Globally

Fact.MR has adopted multi-disciplinary approach to shed light on the evolution of the Absorbent Dressing Market the historical period. The study presents a deep-dive assessment of the current growth dynamics, major avenues in the estimation year of 2019, and key prospects over the forecast period 2018 to 2028. The insights and analytics on several pages. These are covered in numerous sections, including, drivers and restraints, challenges and opportunities, regional segmentation and opportunity assessment, end-use/application prospects analysis, and competitive landscape assessment.

Absorbent dressing is not applicable for dry wounds, thus confining its applications to wet wounds only. Although the overall global absorbent dressing market is anticipated to grow with its escalating demand for burns, accidents and other wound-care, also the rising awareness, availability, affordability and efficacy will elevate the market further. Key players are developing novel absorbent dressing with improved efficacy, healing capacity and safety.

Request for a Brochure: https://www.factmr.com/connectus/sample?flag=S&rep_id=5194  

The global absorbent dressing market is segmented into type, application, end-users and regions. 

By type, the global absorbent dressing market is further segmented into:

  • Traditional Wound Dressings
  • Advanced Wound Dressings 

By application, the global absorbent dressing market is further segmented into:

  • Surgical Wounds
  • Traumatic Wounds 

By end-user, the global absorbent dressing market is further segmented into:

  • Inpatient Facilities
  • Outpatient Facilities

The global absorbent dressing market is poised to lucratively with its high demand wound-care, its efficacy, safety and healing leading to high acceptance. By type, advanced wound dressings lead the absorbent dressing type due to advanced wound dressing foams with anti-microbial and effective healing such as alginates, hydrocolloids, foams, films, collagen, hydrogels and others. By applications, surgical wounds dominate the absorbent dressing application with major attribution by the surgeries of chronic diseases’ surgeries. By end-users, inpatient facilities rule the absorbent dressing market end-users due to the hospitals wherein massive numbers of surgeries are performed, and require admission and stay of patients.

North America holds the largest global absorbent dressing market due to the largest pool of chronic wounds, geriatric populations, increasing healthcare expenditure, key players of absorbing dressing. Europe holds the second largest global absorbent dressing market driven by its highly advanced wound care technology and wide range absorbent dressing products. Asia-pacific absorbent dressing market is growing at the fastest rate with attributing factors such as the giant patient pool of diabetic foot, ulcers, geriatric population, burns and road accidents, in China and India. Latin America absorbent dressing market is growing sound with the high prevalence of chronic wounds, trauma, and other injuries. Improving healthcare infrastructure and rising awareness are also contributing to the regional absorbent dressing market growth. MEA &Africa absorbent dressing market is growing with the rising demand of absorbent dressing for geriatric patients and chronic wound-care including burns, accidents and others.

The key players of global absorbent dressing market include 3M, ConvaTec, Medtronic, Lohmann & Rauscher (L&R), Hollister, Johnson & Johnson, Alliqua BioMedical, Inc., Smith & Nephew, Integra Lifesciences, B. Braun, Coloplast, DeRoyal Inc., Mölnlycke Health Care and DermaRite.

After reading the report, readers get insight into:

  • Major drivers and restraining factors, opportunities and challenges, and the competitive landscape
  • New, promising avenues in key regions
  • New revenue streams for all players in emerging markets
  • Focus and changing role of various regulatory agencies in bolstering new opportunities in various regions
  • Demand and uptake patterns in key industries of the
  • New research and development projects in new technologies in key regional markets
  • Changing revenue share and size of key product segments during the forecast period 2018 to 2028
  • Technologies and business models with disruptive potential

For critical insights on market, request for methodology here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=5194

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
  • EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
  • CIS & Russia
  • Japan
  • Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
  • Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa, Rest of MEA)

The Report Covers Exhaustive Analysis On:

  • Market Segments
  • Market Dynamics
  • Market Size & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

The market report offers detailed assessments and quantitative evaluations that shed light on numerous key aspects that have shaped its evolution over the historical period. In coming years, some of the key aspects that will shape the growth prospects during the forecast period are objectively covered in the study.

Read More Trending Reports of Fact.MR : https://www.biospace.com/article/drug-discovery-services-market-players-are-shifting-towards-r-and-d-outsourcing/

Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape

Prepackaged Medical Kits and Trays Market Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2020 to 2030

Cables and Leads for Medical Equipment Market Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2020 to 2030

Coatings for Medical Devices Market Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2020 to 2030

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-158

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com

Categories
Pharmaceutical

Demand for Ceftriaxone Sodium (API) Market Is Expected to Ramp up at Robust Pace during Forecast 2030

A recent study on the Ceftriaxone Sodium (API) market presents data-driven expert insights and various opportunity assessment frameworks for stakeholders. The business intelligence report on the various growth dynamics of the Ceftriaxone Sodium (API) market helps interested market participants to chart possible evolution trajectories during the forecast period. The study is prepared after completing several rounds of primary research and making extensive secondary research. The analysts or the authors of the study have strived to offers critical scrutiny of the changing vendor landscape, recent macroeconomic upheavals that affect consumer sentiment, and the overall competitive dynamics. The account on the growth dynamics of the Ceftriaxone Sodium (API) market makes a detailed as well as in-depth segmentation to understand the current opportunities and emerging avenues.

Request For A Brochure: https://www.factmr.com/connectus/sample?flag=S&rep_id=5188

In particular, the expert assessment on the emerging growth dynamics offers methods and frameworks for industries, policymakers, and investors to understand the current and emerging avenues in the Ceftriaxone Sodium (API) market. The frameworks offered to facilitate decision making for stakeholders on comprehending the essence of the value chain, and the possibilities that end-use industries offer to the Ceftriaxone Sodium (API) market.

The study offers data and statistics that shape the investment avenues and interests of stakeholders in the key end-use industries and application avenues.

The market analysts and the opinion leaders who have collaborated in offering insights into the growth prospects in the Ceftriaxone Sodium (API) market. Of note, the assessment aims at expanding the understanding of various elements of marketing and supply chains in the currently emerging COVID-era. The new business models and their attractiveness are scrutinized in the new study on the Ceftriaxone Sodium (API) market. 

Some of the new approaches that Fact.MR report analysts strive for analyzing the dynamics of the Ceftriaxone Sodium (API) market can be summed as:

  • The analysts try to decode the hype and the facts that surround the consumer sentiment in the Ceftriaxone Sodium (API) market
  • The report offers the recent disruptions caused by the COVID-19 pandemic and the emergence of new digital models in the Ceftriaxone Sodium (API) market
  • A multidimensional assessment of the key government regulations
  • The recent changes of the outlook of the policymakers of various key countries
  • Workplace diversity that are shaping the strategic realignments
  • Limitations of the evaluation of prevalent consumer preferences

The detailed regional assessment of the global Ceftriaxone Sodium (API) market includes the attractiveness index shaping the avenues in various regions. The data-driven insights also help lay down the foremost factors and trends that is likely to make some regions fast-emerging markets while making some regions maturing during the assessment period. 

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Europe (Germany, U.K, France, Italy, Spain)
  • South Asia (India, ASEAN Countries)
  • East Asia (Japan, China & South Korea)
  • Oceania (Australia & New Zealand)
  • Middle East and Africa (GCC Countries, South Africa, Northern Africa)

Request/View TOC@ https://www.factmr.com/connectus/sample?flag=T&rep_id=5188

The research presents a comprehensive insight into the competitive dynamics and detailed profiling of various industry players. Some of the top players in the Ceftriaxone Sodium (API) market are:

Shandong Luoxin Pharmaceutical Group Stock Co, Livzon Pharmaceutical, United Laboratories, Sinopharm Sandwich, Shanghai Pharmaceutical, North China Pharmaceutical Co., China Union Chempharma, Lupin Pharmaceuticals, Fujian Fukang Pharmaceutical, Qilu Antibiotics Pharmaceutical, Youcare Pharmaceutical Group Co Ltd., Hospira among others. 

Ceftriaxone Sodium (API) Market: Segmentation 

The international ceftriaxone sodium (API) treatment market is segmented based on product type, application type, distribution channel and region. 

By product type, the global ceftriaxone sodium (API) market is segmented as:

  • 5
  • 8 

By application type, the global ceftriaxone sodium (API) market is segmented as:

  • Powder Injection
  • Injection

Some of the insights and trends that help understand the imminent investment pockets in the Ceftriaxone Sodium (API) market are mentioned below:

  • Investment trends of top industry stakeholders
  • Strategies adopted by businesses in various industries that shape the demand in the Ceftriaxone Sodium (API) market
  • Mission-critical priorities that will gain attention among prominent players in the Ceftriaxone Sodium (API) market
  • Share of the leading regional markets in the global Ceftriaxone Sodium (API) market
  • Size of opportunities in emerging regional markets
  • New avenues in various product segments
  • New business models that will gather traction in the near future
  • The game-changing potential that some of the recently unveiled technologies have
  • Patents and research investments that may change the course of the Ceftriaxone Sodium (API) market
  • End-use industries where the demand may gain rapid traction

Browse More Reports by Fact.MR:  https://www.biospace.com/article/bloch-sulzberger-treatment-demand-prompted-by-mounting-number-of-medical-cases-exhibiting-symptoms-of-bloch-sulzberger-syndrome-opines-fact-mr/

Explore Fact.MR’s Coverage on the Biospace Domain

Cervical Dysplasia Diagnostics Market: A recent study by Fact.MR on the cervical dysplasia diagnostics market offers a 10-year forecast analysis for the period 2018 to 2028. The study analyzes key trends that are currently determining the growth of the market.

Cervical Dystonia Treatment Market: Fact. MR’s extensive coverage on cervical dystonia treatment market offers in-depth insights about the prominent growth dynamics that are likely to aid expansion of growth prospects in the near future.

Cervical Anterior Approach Device Package Market: The global cervical anterior approach device package market study published by Fact.MR offers an unbiased analysis of the prominent drivers, opportunities and trends expected to shape future expansion outlook.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-158

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com

Categories
Pharmaceutical

The Vials Leak Testing Market is set to witness steady growth in the coming year 2021-2031

According to the latest research by Fact.MR, The Vials Leak Testing Market is set to witness steady growth in the coming year 2021-2031. The Vials leak testing market is set to grow healthily at a rate of CAGR 7.4% in the forecast period. The expansion of the global automotive, medical & pharmaceutical, and packaging industries along with increasingly stringent regulations pertaining to leakages is likely to spur the demand for the vials leak testing market.

This Market Research Survey by “Fact.MR, A Market Research and Competitive Intelligence Provider” highlights the key reasons behind increasing demand of Vials Leak Testing. Vials Leak Testing market Drivers and constraints, threats and opportunities, regional segmentation and opportunity assessment, end-use/application prospects review are addressed in the Vials Leak Testing market survey report. The survey report provides a comprehensive analysis of Vials Leak Testing market key trends and insights on Vials Leak Testing market size and share. 

To get In-depth Insights Request for Free Brochure here – https://www.factmr.com/connectus/sample?flag=B&rep_id=6421

Key Segments

By Method

  • Vacuum Leak Method
  • Automated Vacuum Leakage Method
  • Internal Pressure Method 

By Equipment Type

  • Portable
  • Fixed

By End users

  • Pharmaceutical Industries
  • Packaging Industries

Key questions answered in Vials Leak Testing Market Survey Report:

  • What is the current scenario and key trends in Vials Leak Testing Market?
  • What are the key strategies companies are adopting to increase their consumer base?
  • What are the key categories within the Vials Leak Testing segments and their future potential?
  • What are the major Vials Leak Testing Market drivers and their expected impact during the short, medium, and long terms?
  • What is the Vials Leak Testing Market size and what are the opportunities for the key players? 

Request Customized Report as Per Your Requirements – https://www.factmr.com/connectus/sample?flag=RC&rep_id=6421

Essential Takeaways from the this Market Report

  • Comparison of prominent players operating in the market.
  • Recent developments and key strategies adopted by key players.
  • Study of the micro and macro-economic growth indicators.
  • Impact of the various factors on the value chain.
  • Evaluation of current Vials Leak Testing market size, forecast and technological advancements within the industry.
  • Current Insights influencing the scenario and key trends in Vials Leak Testing market. 

Covid-19 crisis impact on Vials Leak Testing Market

The rise in the escalation of the Covid-19 virus has led to the rising number of deaths globally and losses to each countries government. Research and Development Department of each country was working on a vaccine for the same and they found the vaccine. Henceforth the rising demand for the covid-19 vaccines globally ensures to put a positive impact on the vials leak testing market globally.

The Report Covers Exhaustive Analysis On:

  • Vials Leak Testing Market Drivers, Segments and Restraints.
  • Vials Leak Testing Market Survey and Dynamics
  • Vials Leak Testing Market Size & Demand
  • Vials Leak Testing Key Trends/Issues/Challenges
  • Vials Leak Testing Sales, Competition & Companies involved

Read More Trending and Similar Reports from Fact.MR – https://www.biospace.com/article/growing-requirement-of-research-activities-to-fuel-demand-for-chromatography-syringes-market-states-fact-mr/

Explore Fact.MR’s Coverage on the Healthcare Domain: 

Leukocyte Count Testing Market – According to the latest research by Fact.MR, the leukocyte count testing market is set to witness exponential growth with over 7%-8% CAGR during 2021-2031. Increasing bacterial infection with the growing adoption of point of care devices will witness a promising growth outlook for leukocyte count testing in the long run.

At-Home Celiac Testing Market – According to the Latest Research by the Fact.MR The Celiac Testing market is set to gain growth in the forecast period 2021-2031 at a CAGR of 8.0%. The Reason for the growth is the increase in prevalence of Celiac disease globally.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-158

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com